Pilot Evaluation of the Unsupervised, At-Home Cogstate Brief Battery in ADNI-2
Background There is a need for feasible, scalable assessments to detect cognitive impairment and decline. The Cogstate Brief Battery (CBB) is validated for Alzheimer’s disease (AD) and in unsupervised and bring your own device contexts. The […]
